Dee Kay Medicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Dee Kay Medicals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manju Bhandari, Usha Subramaniam, and Devendra Bhandari serve as directors at the Company.
- CIN/LLPIN
U52599TN1995PTC030774
- Company No.
030774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dee Kay Medicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manju Bhandari  | Director | 14-Oct-2011 | Current |
| Usha Subramaniam | Director | 01-Feb-2005 | Current |
| Devendra Bhandari | Director | 10-Mar-2006 | Current |
Financial Performance of Dee Kay Medicals.
Dee Kay Medicals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dee Kay Medicals?
In 2017, Dee Kay Medicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ecolux Properties Private LimitedActive 13 years 7 monthsManju Bhandari and Devendra Bhandari are mutual person
- Dev Agrifinance Private LimitedActive 29 years 11 months
Manju Bhandari and Devendra Bhandari are mutual person
- Surana Leasing Private LimitedActive 32 years 2 months
Manju Bhandari and Devendra Bhandari are mutual person
- Fast Aid Finance & Investments LimitedActive 33 years 1 month
Manju Bhandari and Usha Subramaniam are mutual person
- Dtt Financial Services Private LimitedActive 29 years 2 months
Manju Bhandari, Usha Subramaniam and 1 more are mutual person
- Deekay Estates Private LimitedActive 29 years 9 months
Manju Bhandari and Devendra Bhandari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dee Kay Medicals?
Unlock and access historical data on people associated with Dee Kay Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dee Kay Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dee Kay Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
